300573.SZ Stock Analysis
30
Neutral
Based on Eyestock quantitative analysis, 300573.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Shenyang Xingqi Pharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of ophthalmic drugs. The company is headquartered in Shenyang, Liaoning and currently employs 1,279 full-time employees. The company went IPO on 2016-12-08. The Company’s main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The firm mainly distributes its products within domestic market.